Immutep (IMMP) Tax Rate (2012 - 2024)
Immutep's (IMMP) quarterly Tax Rate came in at 84.71% in Q4 2024, down 708.0% YoY from 13.93% in Q1 2024, and down 7.67% on a QoQ basis from 91.75% in Q2 2024.
Immutep (IMMP) Tax Rate (2012 - 2024) Analysis & Trends
Immutep (IMMP) has 8 years of Tax Rate data on file, last reported at 84.71% in Q4 2024.
- Quarterly Tax Rate fell 708.0% year-over-year to 84.71% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 90.99% (down 280.0% YoY) and the FY2022 annual result came in at 0.0%, changed 0.0% from the prior year.
- Tax Rate eased to 84.71% in Q4 2024, from 91.75% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 96.56% in Q4 2021 to a low of 84.71% in Q4 2024.
- A 4-year average of 92.2% and a median of 91.79% in 2023 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2022 — Tax Rate tumbled 35 bps — and 2024, when it sank 708 bps.
- Tracing IMMP's Tax Rate over 4 years: stood at 96.56% in 2021, then declined by 0 bps to 96.21% in 2022, then fell by 5 bps to 91.79% in 2023, then dropped by 8 bps to 84.71% in 2024.
- The last three Tax Rate figures came in at 84.71% (Q4 2024), 91.75% (Q2 2024), and 91.79% (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 7.49% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -16.71% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 34.12% |
| 10 | Immutep | 57.14 Mn | -7.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 84.71% |
| Dec 31, 2024 | 84.71% |
| Dec 31, 2024 | 84.71% |
| Jun 30, 2024 | 91.75% |
| Jun 30, 2024 | 91.75% |
| Jun 30, 2024 | 91.75% |
| Dec 31, 2023 | 91.79% |
| Dec 31, 2023 | 91.79% |
| Dec 31, 2023 | 91.79% |
| Dec 31, 2022 | 96.21% |
| Dec 31, 2022 | 96.21% |
| Dec 31, 2022 | 96.21% |
| Dec 31, 2021 | 96.56% |
| Dec 31, 2021 | 96.56% |
| Dec 31, 2021 | 96.56% |
| Dec 31, 2019 | 85.84% |
| Dec 31, 2019 | 85.84% |
| Dec 31, 2019 | 85.84% |
| Jun 30, 2019 | 90.83% |
| Jun 30, 2019 | 90.83% |